Advertisement

Topics

FDA OKs QVAR RediHaler for Asthma in Children Aged 4+

06:31 EDT 11 Aug 2017 | Medscape

Teva's breath-actuated inhaler for the maintenance treatment of asthma will be available in early 2018 and will replace the older QVAR metered-dose inhaler.
FDA Approvals

Original Article: FDA OKs QVAR RediHaler for Asthma in Children Aged 4+

NEXT ARTICLE

More From BioPortfolio on "FDA OKs QVAR RediHaler for Asthma in Children Aged 4+"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...